Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Conatus Pharmaceuticals Inc.

www.conatuspharma.com

Latest From Conatus Pharmaceuticals Inc.

Pfizer/Novartis Collaboration Brings Combined Strength To NASH Development

Combination therapy is expected to prevail in NASH. Pfizer and Novartis, while trailing smaller companies, are studying their candidates together in hopes of hitting on a winning combo for the multi-factorial disease.

Deals Research & Development

Pipeline Watch: Phase III Starts With Enzastaurin, Sparsentan And Abaloparatide

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

How Do You Solve A Problem Like Biopsy In Alcohol-Associated Liver Disease?

Biopsy results may be informative in early phase trials, but costs have limited their use in US clinical practice, raising questions about whether procedure should be required in drug development.
Research and Development Strategies Gastrointestinal

Common Treatment May Be Removed In Alcoholic Hepatitis Trials

Given effect corticosteroids have on patients, US FDA asks whether they can be excluded from use in alcoholic hepatitis clinical trials.
Gastrointestinal Drug Approval Standards
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Conatus Pharmaceuticals Inc.
  • Senior Management
  • Steven J Mento, PhD, Pres. & CEO
    Michelle L Vandertie, VP, Fin.
    Daniel L Ripley, VP, Bus. Dev. & Program Alliance Mgt.
    Alfred P Spada, PhD, EVP, R&D & CSO
  • Contact Info
  • Conatus Pharmaceuticals Inc.
    Phone: (858) 376-2600
    16745 West Bernardo Dr.
    Ste. 200
    San Diego, CA 92127
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register